Literature DB >> 18550038

Characterization of the solution structure of a neuroligin/beta-neurexin complex.

Davide Comoletti1, Alexander Grishaev, Andrew E Whitten, Palmer Taylor, Jill Trewhella.   

Abstract

Neuroligins are post-synaptic cell adhesion molecules that promote synaptic maturation and stabilization upon binding with pre-synaptic partners, the alpha- and beta-neurexins. Using a combination of analytical ultracentrifugation, small angle X-ray, and neutron scattering, we have characterized the low-resolution three-dimensional structure of the extracellular domain of the neuroligins, free in solution, and in complex with beta-neurexin. The globular extracellular domain of the neuroligins forms stable homodimers through a four-helix bundle typical of the cholinesterases and other members of the alpha/beta-hydrolase fold family. The presence of the stalk region adds to the extracellular domain of neuroligin-1 an elongated structure, suggesting a rod-like nature of the stalk domain. Sedimentation equilibrium coupled with solution scattering data of the beta-neurexin/neuroligin-1 complex indicated a 2:2 stoichiometry where two beta-neurexin molecules bind to a neuroligin-1 dimer. Deuteration of neurexin allowed us to collect neutron scattering data that, in combination with other biochemical techniques, provide a basis for optimizing the positioning of each component in a detailed computational model of the neuroligin/neurexin complex. As several mutations of both neurexin and neuroligin genes have been linked to autism spectrum disorders and mental retardation, these new structures provide an important framework for the study of altered structure and function of these synaptic proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550038      PMCID: PMC2587492          DOI: 10.1016/j.cbi.2008.04.040

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  27 in total

1.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.

Authors:  Stéphane Jamain; Hélène Quach; Catalina Betancur; Maria Råstam; Catherine Colineaux; I Carina Gillberg; Henrik Soderstrom; Bruno Giros; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

2.  Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex.

Authors:  Ben Chih; Leora Gollan; Peter Scheiffele
Journal:  Neuron       Date:  2006-07-20       Impact factor: 17.173

3.  High frequency of neurexin 1beta signal peptide structural variants in patients with autism.

Authors:  Jinong Feng; Richard Schroer; Jin Yan; Wenjia Song; Chunmei Yang; Anke Bockholt; Edwin H Cook; Cindy Skinner; Charles E Schwartz; Steve S Sommer
Journal:  Neurosci Lett       Date:  2006-10-10       Impact factor: 3.046

4.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.

Authors:  Christelle M Durand; Catalina Betancur; Tobias M Boeckers; Juergen Bockmann; Pauline Chaste; Fabien Fauchereau; Gudrun Nygren; Maria Rastam; I Carina Gillberg; Henrik Anckarsäter; Eili Sponheim; Hany Goubran-Botros; Richard Delorme; Nadia Chabane; Marie-Christine Mouren-Simeoni; Philippe de Mas; Eric Bieth; Bernadette Rogé; Delphine Héron; Lydie Burglen; Christopher Gillberg; Marion Leboyer; Thomas Bourgeron
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

5.  O-glycan sialylation and the structure of the stalk-like region of the T cell co-receptor CD8.

Authors:  Anthony H Merry; Robert J C Gilbert; David A Shore; Louise Royle; Olga Miroshnychenko; Mai Vuong; Mark R Wormald; David J Harvey; Raymond A Dwek; Brendan J Classon; Pauline M Rudd; Simon J Davis
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

6.  Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism.

Authors:  Z Talebizadeh; D Y Lam; M F Theodoro; D C Bittel; G H Lushington; M G Butler
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

7.  Gene selection, alternative splicing, and post-translational processing regulate neuroligin selectivity for beta-neurexins.

Authors:  Davide Comoletti; Robyn E Flynn; Antony A Boucard; Borries Demeler; Virgil Schirf; Jianxin Shi; Lori L Jennings; Helen R Newlin; Thomas C Südhof; Palmer Taylor
Journal:  Biochemistry       Date:  2006-10-24       Impact factor: 3.162

8.  Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry.

Authors:  Ross C Hoffman; Lori L Jennings; Igor Tsigelny; Davide Comoletti; Robyn E Flynn; Thomas C Sudhof; Palmer Taylor
Journal:  Biochemistry       Date:  2004-02-17       Impact factor: 3.162

9.  Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta.

Authors:  Davide Comoletti; Robyn Flynn; Lori L Jennings; Alexander Chubykin; Takehito Matsumura; Hana Hasegawa; Thomas C Südhof; Palmer Taylor
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

10.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements.

Authors:  Peter Szatmari; Andrew D Paterson; Lonnie Zwaigenbaum; Wendy Roberts; Jessica Brian; Xiao-Qing Liu; John B Vincent; Jennifer L Skaug; Ann P Thompson; Lili Senman; Lars Feuk; Cheng Qian; Susan E Bryson; Marshall B Jones; Christian R Marshall; Stephen W Scherer; Veronica J Vieland; Christopher Bartlett; La Vonne Mangin; Rhinda Goedken; Alberto Segre; Margaret A Pericak-Vance; Michael L Cuccaro; John R Gilbert; Harry H Wright; Ruth K Abramson; Catalina Betancur; Thomas Bourgeron; Christopher Gillberg; Marion Leboyer; Joseph D Buxbaum; Kenneth L Davis; Eric Hollander; Jeremy M Silverman; Joachim Hallmayer; Linda Lotspeich; James S Sutcliffe; Jonathan L Haines; Susan E Folstein; Joseph Piven; Thomas H Wassink; Val Sheffield; Daniel H Geschwind; Maja Bucan; W Ted Brown; Rita M Cantor; John N Constantino; T Conrad Gilliam; Martha Herbert; Clara Lajonchere; David H Ledbetter; Christa Lese-Martin; Janet Miller; Stan Nelson; Carol A Samango-Sprouse; Sarah Spence; Matthew State; Rudolph E Tanzi; Hilary Coon; Geraldine Dawson; Bernie Devlin; Annette Estes; Pamela Flodman; Lambertus Klei; William M McMahon; Nancy Minshew; Jeff Munson; Elena Korvatska; Patricia M Rodier; Gerard D Schellenberg; Moyra Smith; M Anne Spence; Chris Stodgell; Ping Guo Tepper; Ellen M Wijsman; Chang-En Yu; Bernadette Rogé; Carine Mantoulan; Kerstin Wittemeyer; Annemarie Poustka; Bärbel Felder; Sabine M Klauck; Claudia Schuster; Fritz Poustka; Sven Bölte; Sabine Feineis-Matthews; Evelyn Herbrecht; Gabi Schmötzer; John Tsiantis; Katerina Papanikolaou; Elena Maestrini; Elena Bacchelli; Francesca Blasi; Simona Carone; Claudio Toma; Herman Van Engeland; Maretha de Jonge; Chantal Kemner; Frederieke Koop; Frederike Koop; Marjolein Langemeijer; Marjolijn Langemeijer; Channa Hijmans; Channa Hijimans; Wouter G Staal; Gillian Baird; Patrick F Bolton; Michael L Rutter; Emma Weisblatt; Jonathan Green; Catherine Aldred; Julie-Anne Wilkinson; Andrew Pickles; Ann Le Couteur; Tom Berney; Helen McConachie; Anthony J Bailey; Kostas Francis; Gemma Honeyman; Aislinn Hutchinson; Jeremy R Parr; Simon Wallace; Anthony P Monaco; Gabrielle Barnby; Kazuhiro Kobayashi; Janine A Lamb; Ines Sousa; Nuala Sykes; Edwin H Cook; Stephen J Guter; Bennett L Leventhal; Jeff Salt; Catherine Lord; Christina Corsello; Vanessa Hus; Daniel E Weeks; Fred Volkmar; Maïté Tauber; Eric Fombonne; Andy Shih; Kacie J Meyer
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

View more
  2 in total

1.  Cis and trans actions of the cholinesterase-like domain within the thyroglobulin dimer.

Authors:  Xiaofan Wang; Jaemin Lee; Bruno Di Jeso; A Sonia Treglia; Davide Comoletti; Noga Dubi; Palmer Taylor; Peter Arvan
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

2.  Dystroglycan binding to α-neurexin competes with neurexophilin-1 and neuroligin in the brain.

Authors:  Carsten Reissner; Johanna Stahn; Dorothee Breuer; Martin Klose; Gottfried Pohlentz; Michael Mormann; Markus Missler
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.